Condition: Breast Cancer · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
The goal of this observational study is to develop and validate an artificial intelligence (AI) model for predicting the risk of distant metastasis in patients with primary breast cancer. The main question it aims to answer is: Can a multimodal AI model, trained on routinely available histopathological images, accurately predict the long-term risk of breast cancer metastasis? Researchers will analyze existing hematoxylin and eosin (H\&E) and immunohistochemistry (IHC) stained tissue slides from patients who underwent surgery between 2015 and 2025. Clinical data will be used to train the AI model and evaluate its performance in predicting metastasis.
This description comes directly from the study's public registry record.
Jiaojiao Zhou · 0571-87784527 · zhoujj@zju.edu.cn
Always discuss trial participation with your own doctor first.
| Jilin Cancer Hospital | Changchun, Jilin, China | Not Yet Recruiting |
| Cancer Institute and Hospital, Tianjin Medical University, China | Tianjin, Tianjin Municipality, China | Not Yet Recruiting |
| 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China | Hangzhou, Zhejiang, China | Recruiting |
| The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07244094